Insurance companies that sell policies on and off Connecticut’s Affordable Care Act exchange are seeking an average increase of 20.4% on individual health plans next year, alarming advocates who fear people will forgo insurance because they can’t pay.
The rate hike requests were released by the state Insurance Department Friday. On small group plans, the carriers are asking for an average increase of 14.8%.
The requested increases are substantially higher than those sought last year for 2022 health policies. Carriers in 2021 asked for an average hike of 8.6% on individual plans and 12.9% on small group plans.
“It’s jaw dropping,” said Lynne Ide, program lead for communications outreach and engagement at the Universal Health Care Foundation of Connecticut. “Looking at these rate requests, the ranges are off the charts.
“Our big concern right now is, coupled with inflation and the fallout from COVID, these proposed increases spell trouble. Our concern is that people will take a look at this and decide to go without health coverage, because they just can’t afford it.”
“My jaw hit the floor, obviously,” added Ted Doolittle, the state’s health care advocate. “I’m deeply concerned that people will go without coverage because of these high prices. It is incumbent on the insurance companies and the providers to explain to the people in the state why this is inevitable and there is no alternative.”
Three insurers are selling policies on the exchange: Anthem Health Plans, CTCare Benefits Inc., and ConnectiCare Insurance Company Inc.
Anthem requested an average increase of 8.6% for individual policies that cover 27,698 people. The proposed changes range from a decrease of 1.8% to an increase of 16.1%, depending on the plan.
The company also sought an average hike of 3.6% on small group policies that cover 19,271 residents. The suggested changes range from a decrease of 1.2% to an increase of 26.3%.
CTCare Benefits asked for an average hike of 24.1% on individual plans that cover 75,003 people. Proposed changes range from an increase of 18.7% to 33.2%, depending on the policy.
It also sought an average hike of 22.9% on small group plans that cover 3,476 residents (increases range from 20% to 28.9%).
ConnectiCare Insurance Company, which only sells individual policies on the exchange, requested an average increase of 25.2% for plans that cover 8,782 people. Suggested hikes range from 17.1% to 32.2%.
The proposed increases “don’t seem to make any sense,” Ide said. “Why one carrier would be asking for 8.6% in the individual market on average, and 3.6% in the small group market, and the other carrier is asking for a 24% and 22% in those two markets – it looks like they pulled the numbers out of a hat.”
Proposed increases for plans that are off the exchange are also varied, as the chart below indicates.
Kimberly Kann, a spokeswoman for ConnectiCare, said medical and pharmaceutical costs were some of the factors driving the rate hike request.
“We remain extremely mindful of the impact that rate increases have on our members and strive to keep our plans as fairly priced as possible within the reality of today’s health care environment,” Kan said in a statement. “Our proposed rates are based on several factors, including medical and pharmacy cost trends, along with the continued impacts of COVID-19 on our members’ utilization of services, including obtaining delayed care. Also, the legislative and regulatory environments continue to present market challenges outside of the company’s control, including the loss of the enhanced Advanced Premium Tax Credits provided through the American Rescue Plan Act set to expire in 2022, and state-mandated benefits.”
“We’re proud to have been offering individual plans from the beginning and look forward to continuing to serve people who need these plans,” Alessandra Simkin, a spokeswoman for Anthem, said in a statement. “Our filing reflects our experience and ability to deliver on behalf of consumers in this market and we look forward to working with the state as we continue the regulatory process.”
The insurance department will hold a hearing in early August at which insurers will have a chance to testify on the reasoning behind their proposed increases, and the public will be able to weigh in as well. A date has not yet been set for the hearing.
In addition to the carriers, Doolittle said pharmaceutical company officials and medical providers should attend and provide their rationale for rising costs.
“We’re in a medical cost crisis,” he said. “The rate review process is the one opportunity, the one public forum, that the people of Connecticut have to ask, ‘Why? Why are these hospital prices so high? Why are these drug prices so high?’ The premiums are simply a reflection of the underlying high medical costs.”
“Health care costs and insurance premiums are already unaffordable for many Connecticut families, businesses and individuals, and these double-digit rate hikes demand rigorous scrutiny,” Attorney General William Tong added in a statement. “The Department of Insurance has previously agreed to hold public rate hearings on any rate increase exceeding 10 percent, and that transparency is certainly needed now. We cannot simply allow insurers to assert costs and claims without our own independent analysis and review.”
The public can also submit comments online. Comments may be submitted here (under each policy, click the “select” button and fill in the “comments” box, then hit “submit comment”).
Officials with the insurance department will make a decision on rates for 2023 plans later this year, typically in September. Last year, though carriers sought an average increase of 8.6% on individual plans, the department instead granted a 5.6% average hike.
Open enrollment for 2023 health policies begins Nov. 1.
Wilbur-Ellis Nutrition announced June 30 that it has entered into a definitive agreement to acquire F.L. Emmert, a leading manufacturer and marketer of advanced nutritional solutions for the pet and livestock industries. Emmert is a 140-year-old, family-owned company with manufacturing operations in Cincinnati, Ohio, and 35-plus employees.
"We look forward to welcoming the Emmert team, and we're excited about the capabilities this acquisition provides," said Matt Fanta, president of Wilbur-Ellis Nutrition.
Emmert has a proven track record in animal nutrition, delivering the right balance of brewer's yeast, protein, vitamins, and essential amino acids to support companion animal and livestock health. As a leader in expanding U.S. and global markets, Emmert is also known as an innovator with strong research and development capability.
"Emmert supports Nutrition's strategic priorities and complements our three core businesses – pet, livestock and aquaculture," Fanta said. "The acquisition will expand our product and customer base in pet food with value-added products. We also see great potential for Emmert's research and development capabilities – which complement our own and can be leveraged in the future across the division, including the livestock and aquaculture businesses."
Wilbur-Ellis President and Chief Executive Officer John Buckley noted, "Emmert's capabilities are a great fit for the Nutrition business, bringing greater balance and diversification to the division's portfolio. The acquisition also supports the company's broader strategy to continue building on our position as a leading agriculture and food company in North America."
Along with a strong business fit, Buckley and Fanta highlighted the similar values and culture of Emmert and Wilbur-Ellis. In 2021, Wilbur-Ellis celebrated its 100th anniversary and is one of the largest family-owned companies in the United States. With Emmert's 140-year-plus history as a family-owned business, the two companies share a long-term view and similar values.
"Wilbur-Ellis has a long history of growth through acquisition," Fanta noted. "And in every case, having similar values has been an important consideration. With that in mind, we look forward to having such a strong, value-based organization like Emmert become part of the Wilbur-Ellis Nutrition business."
Consummation of the acquisition remains subject to the satisfaction of customary closing conditions.